Inventor
MATZKE MICHAEL
DE32 patents
Patents
32 patentsUS6133260AOct 17, 2000
Use of 7-(2-oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-quinolone carboxylic acid and naphthyridon carboxylic acid derivatives for the treatment of Helicobacter pylori infections and associated gastroduodenal diseases
BAYER AG40 citations96
US6573278B2Jun 3, 2003
Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
BAYER AG61 citations95
US6284788B1Sep 4, 2001
Use of known agonists of the central cannabinoid receptor CB1
BAYER AG65 citations95
US6262112B1Jul 17, 2001
Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
BAYER AG64 citations95
US5935988AAug 10, 1999
Tolerability of pharmaceutically active β-amino acids
BAYER AG62 citations94
US6545050B1Apr 8, 2003
Aryl sulphonamide amino acid esters and analogues
BAYER AG30 citations92
US5521206AMay 28, 1996
Heterocyclically substituted phenylacetic acid derivatives and their use in medicaments
BAYER AG20 citations92
US5492896AFeb 20, 1996
Pseudopeptides having an antiviral action
BAYER AG24 citations92
US6469054B1Oct 22, 2002
Aryl sulphonamides and analogues
BAYER AG33 citations91
US6288081B1Sep 11, 2001
Use of 7-(1-aminomethyl-2-oxa-7-aza-bicyclo[3.3.0]oct-7-yl)-quinolone carboxylic acid and naphthyridone carboxylic acid derivatives for treating Helicobacter pylori infections and the gastroduodenal diseases associated therewith
BAYER AG6 citations74
US5739160AApr 14, 1998
Cyclopentane- and -pentene-β-amino acids
BAYER AG9 citations74
US5691337ANov 25, 1997
Oxy-phenyl-(phenyl)glycinolamides with heterocyclic substituents
BAYER AG9 citations74
US5646162AJul 8, 1997
Oxy-phenyl-(phenyl)glycinolamides with heterocyclic substituents
BAYER AG10 citations74
US5631291AMay 20, 1997
Cyclopentane- and -pentene-β-amino acids
BAYER AG10 citations74
US6525087B2Feb 25, 2003
Use of known agonists of the central cannabinoid receptor CB1
BAYER AG10 citations73
US5776964AJul 7, 1998
Heterocyclically substituted phenylacetic acid derivatives and their use in medicaments
BAYER AG6 citations73
US5292769AMar 8, 1994
Substituted mandelic acid derivatives and their use in medicaments
BAYER AG7 citations73
US5283252AFeb 1, 1994
Thiazolyl-substituted quinolylmethoxyphenylacetic acid derivatives
BAYER AG7 citations73
US5266578ANov 30, 1993
Heterocyclically substituted quinolylmethoxy-phenylacetamides
BAYER AG7 citations73
US6444828B1Sep 3, 2002
Method for preparing 1-alkyl-pyrazol-5-carboxylic acid esters III
BAYER AG2 citations63
US6432948B1Aug 13, 2002
Use of 7-(2-oxa-5,8-diazabicylco[4.3.0]non-8-yl)-quinolone carboxylic acid and naphthyridon carboxylic acid derivatives for the treatment of heliobacter pylori infections and associated gastroduodenal diseases
BAYER AG3 citations63
US5770622AJun 23, 1998
Method of preserving materials using 4-methylene-2-amino-cyclopentane-1-carboxylic acids
BAYER AG2 citations63
US5962724AOct 5, 1999
High enantio-selective process for producing pure enantiomeric cyclopentane and cyclopentene-(β)-amino acids
BAYER AG2 citations62
US5399698AMar 21, 1995
Quinolin-2-yl-methoxybenzylhydroxyureas
BAYER AG2 citations62
US5310744AMay 10, 1994
Quinolylmethoxyphenyl-acetamides
BAYER AG3 citations62
US5304563AApr 19, 1994
2-substituted quinolines, and their use in medicaments
BAYER AG5 citations62
US5231103AJul 27, 1993
Quinolin-2-yl-methoxybenzylhydroxyureas
BAYER AG2 citations62
US6727279B2Apr 27, 2004
Arylsulphonamides and analogues
BAYER AG3 citations61
US5663150ASep 2, 1997
Cyclopentane-β-amino acid tripeptides
BAYER AG3 citations61
US5597833AJan 28, 1997
Substituted quinol-2-yl-methoxy-phenylacetic acid derivatives
BAYER AG4 citations60
US5288733AFeb 22, 1994
Quinolylmethoxyphenylacetic acid acylamides and ureas
BAYER AG1 citations49
US6297386B1Oct 2, 2001
Method of preparing 1-alkyl-pyrazol-5-carboxylic acid esters
BAYER AG0 citations42